Furthermore, the study uncovered that the downregulation of H3K18la levels inhibits the transcriptional activity of the ADIPOQ gene, which is a key factor contributing to the diminished ADIPOQ levels in psoriasis patients 304(Fig. 8). The gene discussed is ADIPOQ; the disease is psoriasis.